10x Genomics (TXG) Research & Development (2018 - 2026)
10x Genomics (TXG) posted Research & Development of $56.8 million for Q1 2026, up 1.57% sequentially from $56.0 million in Q4 2025, and down 11.52% YoY from $64.2 million in Q1 2025.
10x Genomics (TXG) Research & Development (2018 - 2026) Analysis & Trends
10x Genomics has reported Research & Development for 9 years, with the latest figure at $56.8 million in Q1 2026.
- Quarterly Research & Development fell 11.52% year-over-year to $56.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $231.2 million (down 11.17% YoY) and the FY2025 annual result came in at $238.6 million, down 9.85% from the prior year.
- Research & Development advanced to $56.8 million in Q1 2026 per TXG's latest filing, from $56.0 million in the prior quarter.
- Over five years, Research & Development peaked at $71.5 million in Q2 2023 and troughed at $56.0 million in Q4 2025.
- A 5-year average of $64.5 million and a median of $65.3 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development soared 52.99% in 2022, then declined 16.42% in 2025.
- Over 5 years, Research & Development stood at $63.6 million in 2022, then increased by 2.6% to $65.3 million in 2023, then climbed by 2.61% to $67.0 million in 2024, then dropped by 16.42% to $56.0 million in 2025, then gained by 1.57% to $56.8 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $56.8 million, $56.0 million, and $57.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 56.79 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 81.41 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 50.38 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 45.05 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 30.58 Mn |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.79 Mn |
| Mar 31, 2026 | 56.85 Mn |
| Dec 31, 2025 | 55.97 Mn |
| Sep 30, 2025 | 57.19 Mn |
| Jun 30, 2025 | 61.22 Mn |
| Mar 31, 2025 | 64.25 Mn |
| Dec 31, 2024 | 66.97 Mn |
| Sep 30, 2024 | 66.17 Mn |
| Jun 30, 2024 | 62.92 Mn |
| Mar 31, 2024 | 68.64 Mn |
| Dec 31, 2023 | 65.27 Mn |
| Sep 30, 2023 | 66.51 Mn |
| Jun 30, 2023 | 71.46 Mn |
| Mar 31, 2023 | 67.10 Mn |
| Dec 31, 2022 | 63.61 Mn |
| Sep 30, 2022 | 67.29 Mn |
| Jun 30, 2022 | 70.69 Mn |
| Mar 31, 2022 | 64.08 Mn |
| Dec 31, 2021 | 61.89 Mn |
| Sep 30, 2021 | 54.58 Mn |